211 related articles for article (PubMed ID: 10870093)
1. Pharmacokinetics and tissue distribution of olanzapine in rats.
Aravagiri M; Teper Y; Marder SR
Biopharm Drug Dispos; 1999 Nov; 20(8):369-77. PubMed ID: 10870093
[TBL] [Abstract][Full Text] [Related]
2. Disposition of the novel anti-schizophrenic drug [14C]olanzapine in male Fischer 344 and female CD rats following single oral dose administration.
Chay SH; Herman JL
Arzneimittelforschung; 1998 May; 48(5):446-54. PubMed ID: 9638310
[TBL] [Abstract][Full Text] [Related]
3. Brain, plasma and tissue pharmacokinetics of risperidone and 9-hydroxyrisperidone after separate oral administration to rats.
Aravagiri M; Marder SR
Psychopharmacology (Berl); 2002 Feb; 159(4):424-31. PubMed ID: 11823895
[TBL] [Abstract][Full Text] [Related]
4. Analysis and pharmacokinetics of olanzapine (LY170053) and two metabolites in rat plasma using reversed-phase HPLC with electrochemical detection.
Chiu JA; Franklin RB
J Pharm Biomed Anal; 1996 Mar; 14(5):609-15. PubMed ID: 8738191
[TBL] [Abstract][Full Text] [Related]
5. Quantitative determination of olanzapine in rat brain tissue by high-performance liquid chromatography with electrochemical detection.
Bao J; Potts BD
J Chromatogr B Biomed Sci Appl; 2001 Mar; 752(1):61-7. PubMed ID: 11254198
[TBL] [Abstract][Full Text] [Related]
6. Distribution after repeated oral administration of different dose levels of risperidone and 9-hydroxy-risperidone in the brain and other tissues of rat.
Aravagiri M; Yuwiler A; Marder SR
Psychopharmacology (Berl); 1998 Oct; 139(4):356-63. PubMed ID: 9809856
[TBL] [Abstract][Full Text] [Related]
7. Influence of ritonavir on olanzapine pharmacokinetics in healthy volunteers.
Penzak SR; Hon YY; Lawhorn WD; Shirley KL; Spratlin V; Jann MW
J Clin Psychopharmacol; 2002 Aug; 22(4):366-70. PubMed ID: 12172335
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299
[TBL] [Abstract][Full Text] [Related]
9. Olanzapine pharmacokinetics are similar in Chinese and Caucasian subjects.
Sathirakul K; Chan C; Teng L; Bergstrom RF; Yeo KP; Wise SD
Br J Clin Pharmacol; 2003 Aug; 56(2):184-7. PubMed ID: 12895191
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, randomized trial to evaluate the pharmacokinetics and tolerability of 30 or 40 mg/d oral olanzapine relative to 20 mg/d oral olanzapine in stable psychiatric subjects.
Mitchell M; Riesenberg R; Bari MA; Marquez E; Kurtz D; Falk D; Hardy T; Taylor CC; Mitchell CP; Cavazzoni P
Clin Ther; 2006 Jun; 28(6):881-92. PubMed ID: 16860171
[TBL] [Abstract][Full Text] [Related]
11. Olanzapine. Pharmacokinetic and pharmacodynamic profile.
Callaghan JT; Bergstrom RF; Ptak LR; Beasley CM
Clin Pharmacokinet; 1999 Sep; 37(3):177-93. PubMed ID: 10511917
[TBL] [Abstract][Full Text] [Related]
12. Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infants.
Gardiner SJ; Kristensen JH; Begg EJ; Hackett LP; Wilson DA; Ilett KF; Kohan R; Rampono J
Am J Psychiatry; 2003 Aug; 160(8):1428-31. PubMed ID: 12900304
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and tissue distribution of halofuginone (NSC 713205) in CD2F1 mice and Fischer 344 rats.
Stecklair KP; Hamburger DR; Egorin MJ; Parise RA; Covey JM; Eiseman JL
Cancer Chemother Pharmacol; 2001 Nov; 48(5):375-82. PubMed ID: 11761455
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist. 4th communication: tissue distribution, placental transfer and milk secretion of radioactivity in rats after a single oral administration of 14C-NS-49, and effects of repeated administration on its pharmacokinetics.
Dalrymple PD; Beeby TL; Mukai H; Chasseaud LF
Arzneimittelforschung; 2001; 51(5):394-401. PubMed ID: 11413740
[TBL] [Abstract][Full Text] [Related]
15. A pharmacokinetic interaction between carbamazepine and olanzapine: observations on possible mechanism.
Lucas RA; Gilfillan DJ; Bergstrom RF
Eur J Clin Pharmacol; 1998 Oct; 54(8):639-43. PubMed ID: 9860152
[TBL] [Abstract][Full Text] [Related]
16. Olanzapine disposition in humans is unrelated to CYP1A2 and CYP2D6 phenotypes.
Hägg S; Spigset O; Lakso HA; Dahlqvist R
Eur J Clin Pharmacol; 2001 Sep; 57(6-7):493-7. PubMed ID: 11699614
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats.
Egorin MJ; Lagattuta TF; Hamburger DR; Covey JM; White KD; Musser SM; Eiseman JL
Cancer Chemother Pharmacol; 2002 Jan; 49(1):7-19. PubMed ID: 11855755
[TBL] [Abstract][Full Text] [Related]
18. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
[TBL] [Abstract][Full Text] [Related]
19. Toxicokinetics of p-tert-octylphenol in male Wistar rats.
Certa H; Fedtke N; Wiegand HJ; Müller AM; Bolt HM
Arch Toxicol; 1996; 71(1-2):112-22. PubMed ID: 9010593
[TBL] [Abstract][Full Text] [Related]
20. Olanzapine pharmacokinetics in pediatric and adolescent inpatients with childhood-onset schizophrenia.
Grothe DR; Calis KA; Jacobsen L; Kumra S; DeVane CL; Rapoport JL; Bergstrom RF; Kurtz DL
J Clin Psychopharmacol; 2000 Apr; 20(2):220-5. PubMed ID: 10770461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
